These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21446173)

  • 1. [Study of efficacy of anaferon pediatric in mice infected by pandemic influenza virus A(H1N1/09)v].
    Shishkina LI; Skarnovich MO; Kabanov AS; Sergeev AA; Tarasov SA; Sergeeva SA; Épshteĭn ; Malkova EM; Stavskiĭ EA; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):83-6. PubMed ID: 21446173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09).
    Shishkina LN; Skarnovich MO; Kabanov AS; Sergeev AA; Olkin SE; Tarasov SA; Belopolskaya MV; Sergeeva SA; Epstein OI; Malkova EM; Stavsky EA; Drozdov IG
    Bull Exp Biol Med; 2010 Oct; 149(5):612-4. PubMed ID: 21165400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
    Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
    J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
    Skarnovich MA; Emelyanova AG; Petrova NV; Borshcheva AA; Gorbunov EA; Mazurkov OY; Skarnovich MO; Tarasov SA; Shishkina LN; Epstein OI
    Antivir Ther; 2017; 22(4):345-351. PubMed ID: 27924780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
    Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v].
    Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Mazurkova NA; Sergeev AA; Serova OA; Stavskiĭ EA; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):93-6. PubMed ID: 21598625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infection.
    Shishkina LN; Sergeev AN; Kabanov AS; Skarnovich MO; Evtin NK; Mazurkova NA; Sergeev AA; Belopolskaya MV; Kheyfets IA; Dugina JL; Tarasov SA; Sergeeva SA; Epstein OI
    Bull Exp Biol Med; 2008 Dec; 146(6):763-5. PubMed ID: 19513378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
    Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
    Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.
    Tarasov SA; Zarubaev VV; Gorbunov EA; Sergeeva SA; Epstein OI
    Antiviral Res; 2012 Feb; 93(2):219-224. PubMed ID: 22178245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
    Baz M; Carbonneau J; Rhéaume C; Cavanagh MH; Boivin G
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30400276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of TheraMax on influenza virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH
    Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
    Don ЕS; Emelyanova AG; Yakovleva NN; Petrova NV; Nikiforova MV; Gorbunov EA; Tarasov SА; Morozov SG; Epstein ОI
    J Med Virol; 2017 May; 89(5):759-766. PubMed ID: 27769099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian pathogenesis of oseltamivir-resistant pandemic (H1N1) 2009 influenza virus isolated in South Korea.
    Kwon D; Shin K; Kim SJ; Lee JY; Kang C
    Virus Res; 2014 Jun; 185():41-6. PubMed ID: 24657788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of L-N
    Smee DF; Dagley A; Tarbet EB
    Antivir Chem Chemother; 2017 Apr; 25(1):11-17. PubMed ID: 28417640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
    Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
    J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets.
    Hamelin ME; Baz M; Bouhy X; Beaulieu E; Dubé K; Mallett C; Boivin G
    Antivir Ther; 2011; 16(5):775-9. PubMed ID: 21817200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.
    Leyva-Grado VH; Palese P
    Antiviral Res; 2017 Jun; 142():12-15. PubMed ID: 28286235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of combined administration of ridostin and oseltamivir (tamiflu) for therapy and prophylaxis of experimental infection induced by influenza virus A (H5N1) in mice].
    Skarnovich MO; Shishkina LN; Kabanov AS; Mazurkova NA; Danilenko ED; Masycheva VI; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (5):79-82. PubMed ID: 22145356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.